HomeAKTX • NASDAQ
add
Akari Therapeutics PLC
Previous close
$1.14
Day range
$1.08 - $1.14
Year range
$0.90 - $4.40
Market cap
30.35M USD
Avg Volume
47.98K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.85M | -51.24% |
Net income | -2.90M | 17.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.85M | 51.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.25M | -41.59% |
Total assets | 2.73M | -37.22% |
Total liabilities | 9.43M | 105.67% |
Total equity | -6.69M | — |
Shares outstanding | 24.76M | — |
Price to book | -2.07 | — |
Return on assets | -118.57% | — |
Return on capital | 110.28% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.90M | 17.40% |
Cash from operations | -1.49M | 56.55% |
Cash from investing | — | — |
Cash from financing | -443.00K | -125.19% |
Net change in cash | -1.93M | -15.78% |
Free cash flow | -140.62K | — |
About
Founded
2004
Headquarters
Website
Employees
7
